Stomach cancer natural history, complications and prognosis

Revision as of 19:32, 14 November 2017 by Medhat (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Stomach cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stomach Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Endoscopy and Biopsy

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Stomach cancer natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stomach cancer natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stomach cancer natural history, complications and prognosis

CDC on Stomach cancer natural history, complications and prognosis

Stomach cancer natural history, complications and prognosis in the news

Blogs on Stomach cancer natural history, complications and prognosis

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Stomach cancer natural history, complications and prognosis

Overview

Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.

Natural History

Metastasis occurs in 80-90% of individuals with stomach cancer. without treatment, 63 percent of patients with early gastric cancer will progress to advanced stage disease within five years [73].

Complications

In a Japanese series, 58 of 633 patients (9.2 percent) with early gastric cancers had synchronous cancers, defined as a second cancer found within the first year [94]. the overall incidence of metachronous cancers was 8.2 percent, the majority of which were able to be resected endoscopically. the cumulative incidence of metachronous early gastric cancers was 9.5 percent at five years, 13.1 percent at seven years, and 22.7 percent at 10 years [92].

Prognosis

5-Year Survival

The overall five-year survival rate for treated early gastric cancer in most modern era series is over 90 percent: nearly 100 percent for mucosal tumors, and 80 to 90 percent for submucosal tumors [75-78].

Survival rates are similar between patients who undergo endoscopic resection and those who undergo surgical resection (five-year survival of 96 and 94 percent in one study) [79-81]. The recurrence rate after surgery is approximately 1 to 5 percent in reports from Korea [79,82] and Japan [83] and 5 to 15 percent in studies from Western centers [84]. These variable recurrence rates partially reflect differences in length of follow-up, but may also be due to differences in the pathologic diagnosis of malignancy [85]. Among patients undergoing endoscopic resection, recurrence rates have been reported to be between 0 and 30 percent [17,18,22,31,79,83,86-88]. Higher recurrence rates are seen with those who have piecemeal or incomplete resections.

Prognosis with lymph node involvement 

The literature suggests that up to 10 percent of mucosal early gastric cancers and 20 to 30 percent of submucosal early gastric cancers will have lymph node metastases [3,95-98].

long-term survival was 95 percent in patients with no lymph node involvement, 88 percent in those with one to three nodes involved, and 77 percent in those with more than three nodes involved [63].

  • Between 2004 and 2010, the 5-year relative survival of patients with stomach cancer was 29%.[1]
  • When stratified by age, the 5-year relative survival of patients with stomach cancer was 31.4% and 26% for patients <65 and ≥ 65 years of age respectively.[1]
  • The survival of patients with stomach cancer varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of stomach cancer:[1]
Stage 5-year relative survival (%), (2004-2010)
All stages 28.3%
Localized 64.1%
Regional 28.8%
Distant 4.2%
Unstaged 20.2%
  • Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 1998 and 2010 of stomach cancer by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[1]

<figure-inline class="mw-default-size"></figure-inline>

References

  1. 1.0 1.1 1.2 1.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WH Template:WS